Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Vaccine Refusal clinical trials

2 of 6 indexed Vaccine Refusal trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Vaccine Refusal: 6 US clinical trials tracked, 2 recruiting.

Vaccine Refusal is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Corewell Health East, running 1 of these trials.

Enrollment posture brief

Registry condition vaccine-refusal

OPEN 2 | RECR 33% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Vaccine Refusal (this)33%
Open-enrollment share among volume-matched conditions near Vaccine Refusal

Vaccine Refusal lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vaccine Refusal on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vaccine Refusal is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Vaccine Refusal research.

    Corewell Health East accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Vaccine Refusal enrolment sits around 1,000 participants.

    Median target enrolment is 1,000 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.

  4. Vaccine Refusal splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Vaccine Refusal records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Simple forewarning message Behavioral
1 trials
Argument inoculation messages Behavioral
1 trials
Messaging informed by construal level theory Behavioral
1 trials
Standardized patient (SP) encounter Other
1 trials
Immersive resident education Other
1 trials
web-based survey Other
1 trials
Appointment Reminder Message Other
1 trials
LetsTalkShots (provider-facing CDS) Other
1 trials

US sites by state

Facility locations filed on Vaccine Refusal trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
Pennsylvania 1 trials
Missouri 1 trials
Michigan 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vaccine Refusal page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vaccine Refusal condition card totals 6 registered trials; most-linked intervention Simple forewarning message; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.